The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Tue., Sep. 17, 9:21 AM

Slide #8. Neuralstem, Inc. (NASDAQ:CUR) 1 for 20 Reverse Split

Announced: 7/16/2019
Stock Split: 1 for 20
Record Date: 7/16/2019
Pay Date: 7/17/2019
CUR Optionable?: Yes

Neuralstem is a clinical stage biopharmaceutical company that is utilizing its proprietary human neural stem cell technology to create a platform of therapies for the treatment of central nervous system diseases. Co.'s technology platform has produced four key assets, two in clinical development and two in preclinical development: its NSI-566 stem cell therapy program (clinical stage) for treatment of paralysis, NSI-189 small molecule program (clinical stage) for Major Depressive Disorder and NSI-532 for Alzheimer's Disease and NSI-577 indicated for potential use in treatment of human demyelinating diseases, both of which are second-generation stem cell therapy programs (preclinical stage).
CUR Detailed Information Page & Split History »

Company Name: 
Neuralstem Inc
Website: 
www.neuralstem.com
Sector: 
Biotechnology
Number of ETFs Holding CUR: 
2
Total Market Value Held by ETFs: 
$14906
Total Market Capitalization: 
$4.00M
% of Market Cap. Held by ETFs: 
0.37%

Open the CUR Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.